Yong Teng

9.1k citations
178 papers · 6.4k indexed · 3 hit papers · h-index 41
Topics
Cancer, Hypoxia, and Metabolism (19 papers)RNA modifications and cancer (17 papers)Epigenetics and DNA Methylation (14 papers)
Partner nations
United StatesChinaIran

In The Last Decade

Yong Teng

170 papers receiving 6.3k citations

Hit Papers

Is It Time to Start Transitioning From 2D to 3D Cell Cult...20202026202220242020202120242505007501000

Peers

Yong Teng
Comparison fields: 5 of 141
  • Molecular Biology 3.7k
  • Cancer Research 1.5k
  • Oncology 1.3k
  • Biomedical Engineering 965
  • Immunology 909
Replace Li Fu with:
Li Fu China
Paule Opolon France
Ke Tang China
Lunquan Sun China
Don L. Gibbons United States
Raija Sormunen Finland
Karl R. Clauser United States
Lei Yao China
Toshiharu Yamashita Japan
Hui Feng China
Yong Teng relative to Li Fu China Li Fu's profile →
Citations per field
00.5×1.5×1.9×
Li Fu · 1×
Citations per year

Countries citing papers authored by Yong Teng

Since Specialization
Citations

This map shows the geographic impact of Yong Teng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Teng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Teng more than expected).

Fields of papers citing papers by Yong Teng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong Teng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Teng. The network helps show where Yong Teng may publish in the future.

Co-authorship network of co-authors of Yong Teng

This figure shows the co-authorship network connecting the top 25 collaborators of Yong Teng. A scholar is included among the top collaborators of Yong Teng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong Teng. Yong Teng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 1
3 0
4 9
5 8
6 21
7 16
8 16
9 8
10 10
11 1
12 12
13 17
14 14
15 15
16 10
17 70
18 59
19 53
20 17

About Yong Teng

Yong Teng is a scholar working on Cancer Research, Otorhinolaryngology and Molecular Biology, having authored 178 papers that have together received 6.4k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (19 papers), RNA modifications and cancer (17 papers) and Epigenetics and DNA Methylation (14 papers). The work is most often cited by research in Cancer Research (1.5k citations), Molecular Biology (3.7k citations) and Oncology (1.3k citations). Yong Teng has collaborated with scholars based in United States, China and Iran. Frequent co-authors include Caleb Jensen, John K. Cowell, Chloe Shay, Lixia Gao, Liwei Lang, Reid Loveless, Xiayang Xie, Ryan F. Bloomquist, Manran Liu and Yixuan Hou. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026